RPbio알피바이오
314140 · KOSDAQ · ₩314140 · 알피바이오
₩5,300▲ ₩30 (0.57%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Gross margin | 11.6% | 10.2% | 5.8% | 10.3% | 12.9% |
| Operating margin | 5.3% | 3.7% | −0.6% | 4.4% | 7.0% |
| Net margin | 4.8% | 3.4% | −0.7% | 3.6% | 3.1% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue growth | +3.8% | +9.9% | −17.9% | +9.4% | — |
| Operating income growth | +46.9% | +833.3% | −110.5% | −31.3% | — |
| Net income growth | +43.6% | +616.2% | −116.7% | +26.0% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Return on equity | 6.0% | 4.5% | −0.9% | 5.6% | 4.7% |
| Return on assets | 4.1% | 3.0% | −0.6% | 3.2% | 2.5% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Liabilities to equity | 46.0% | 45.8% | 55.9% | 61.8% | 90.0% |
| Net debt to equity | 0.6% | 2.8% | 6.7% | 13.0% | 19.8% |
| Current ratio | 141.6% | 129.7% | 119.4% | 117.8% | 103.1% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: RPbio / 알피바이오 / 314140 / KRX:314140
Source: KRX statistical information